You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: February 25, 2020

DrugPatentWatch Database Preview

Patent: 9,877,971

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,877,971
Title:Soft lozenges comprising corticosteroids
Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising non-systemic corticosteroid soft lozenges, methods for making the same, and methods for treating subjects in need thereof with such lozenges. In particular, the oral composition provides topical, non-systemic administration of one or more active pharmaceutical ingredients to the oral cavity and upper gastrointestinal track, including the esophagus. In one embodiment, the oral pharmaceutical compositions comprise chewable, suckable, or buccally-dissolvable soft lozenges for the treatment of esophageal lesions. The soft lozenges provide topical, non-systemic delivery of corticosteroids to the esophagus and oral cavity.
Inventor(s): Zhao; Yinyan (Greensboro, NC), Hughey; Justin (Asheboro, NC), Vaughn; Jason (Browns Summit, NC), Fang; Qi (Oak Ridge, NC)
Assignee: Banner Life Sciences LLC (High Point, NC)
Application Number:15/181,462
Patent Claims:see list of patent claims

Details for Patent 9,877,971

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Start Trial Banner Life Sciences LLC (High Point, NC) 2035-06-15 RX Orphan search
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20   Start Trial Banner Life Sciences LLC (High Point, NC) 2035-06-15 RX search
Glaxosmithkline Llc NUCALA mepolizumab INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER 125526 001 2015-11-04   Start Trial Banner Life Sciences LLC (High Point, NC) 2035-06-15 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.